Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TARS – Tarsus Pharmaceuticals Inc

Float Short %

21.1

Margin Of Safety %

Put/Call OI Ratio

0.18

EPS Next Q Diff

0.45

EPS Last/This Y

1.57

EPS This/Next Y

1.53

Price

57.19

Target Price

76.25

Analyst Recom

1.25

Performance Q

33.23

Relative Volume

0.96

Beta

0.77

Ticker: TARS




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25TARS41.573.160.301398
2025-07-28TARS41.763.07999.991419
2025-07-29TARS40.213.080.041425
2025-07-30TARS40.022.890.001450
2025-07-31TARS38.822.540.151501
2025-08-01TARS40.992.56999.991505
2025-08-04TARS41.92.570.331508
2025-08-05TARS41.142.57117.171508
2025-08-06TARS41.694.1990.822223
2025-08-07TARS47.926.410.243214
2025-08-08TARS47.85.760.573281
2025-08-11TARS50.075.740.083283
2025-08-12TARS51.364.815.003377
2025-08-13TARS52.74.780.023369
2025-08-14TARS54.154.730.083375
2025-08-15TARS54.224.630.003391
2025-08-18TARS54.650.120.00561
2025-08-19TARS53.70.130.00566
2025-08-20TARS55.460.121.59570
2025-08-21TARS56.560.190.08627
2025-08-22TARS57.240.180.22678
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25TARS41.5050.5- -1.24
2025-07-28TARS41.5850.5- -1.24
2025-07-29TARS40.1457.0- -1.06
2025-07-30TARS40.0057.0- -1.06
2025-07-31TARS38.8257.0- -1.06
2025-08-01TARS40.8157.0- -1.06
2025-08-04TARS41.9157.0- -1.06
2025-08-05TARS41.1557.0- -1.06
2025-08-06TARS41.6657.0- -1.06
2025-08-07TARS47.9557.0- -1.06
2025-08-08TARS47.8580.3- -0.94
2025-08-11TARS50.0780.3- -0.94
2025-08-12TARS51.3644.7- -1.52
2025-08-13TARS52.7244.7- -1.52
2025-08-14TARS54.1744.7- -1.52
2025-08-15TARS54.2142.6- -1.52
2025-08-18TARS54.5742.6- -1.52
2025-08-19TARS53.7042.2- -1.50
2025-08-20TARS55.4742.2- -1.50
2025-08-21TARS56.5542.2- -1.50
2025-08-22TARS57.1942.2- -1.50
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25TARS-2.6110.0121.46
2025-07-28TARS-2.619.5721.46
2025-07-29TARS-2.619.5721.46
2025-07-30TARS-2.619.5721.46
2025-07-31TARS-2.619.5721.46
2025-08-01TARS-2.619.5721.46
2025-08-04TARS-2.618.2121.46
2025-08-05TARS-2.618.2121.46
2025-08-06TARS-2.618.2121.46
2025-08-07TARS-2.618.2121.46
2025-08-08TARS-2.618.2121.46
2025-08-11TARS-2.598.0921.35
2025-08-12TARS-2.598.0921.17
2025-08-13TARS-2.748.0921.17
2025-08-14TARS-2.748.0921.17
2025-08-15TARS-2.748.0921.17
2025-08-18TARS-2.748.9221.10
2025-08-19TARS-2.848.9221.10
2025-08-20TARS-2.848.9221.10
2025-08-21TARS-2.848.9221.10
2025-08-22TARS-2.848.9221.10
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

-0.48

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

-2.84

Institutional Transactions

8.92

Beta

0.77

Average Sales Estimate Current Quarter

113

Average Sales Estimate Next Quarter

131

Fair Value

Quality Score

47

Growth Score

56

Sentiment Score

83

Actual DrawDown %

10.2

Max Drawdown 5-Year %

Target Price

76.25

P/E

Forward P/E

58.85

PEG

P/S

8.18

P/B

7.27

P/Free Cash Flow

EPS

-2.33

Average EPS Est. Cur. Y​

-1.5

EPS Next Y. (Est.)

0.03

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-31.13

Relative Volume

0.96

Return on Equity vs Sector %

-52.3

Return on Equity vs Industry %

-39.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.43

EBIT Estimation

Tarsus Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 323
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
stock quote shares TARS – Tarsus Pharmaceuticals Inc Stock Price stock today
news today TARS – Tarsus Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch TARS – Tarsus Pharmaceuticals Inc yahoo finance google finance
stock history TARS – Tarsus Pharmaceuticals Inc invest stock market
stock prices TARS premarket after hours
ticker TARS fair value insiders trading